JBGlobal.com’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221K Hold
1,550
– – 0.2% 33
2026
Q2
$243K Hold
1,550
– – 0.21% 30
2026
Q1
$237K Hold
1,550
– – 0.23% 27
2025
Q4
$214K Buy
+1,550
New +$203K 0.27% 19
2025
Q3
– Sell
-1,689
Closed -$204K – 30
2025
Q2
$204K Buy
+1,689
New +$190K 0.21% 28

Other funds holding NVS

JBGlobal.com's NVS Position: Q3 2026 in Review

JBGlobal.com held its Novartis (NVS) position steady in Q3 2026 at 1,550 shares worth $221K. The position accounts for 0.2% of the portfolio, ranked #33.

JBGlobal.com first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $243K in Q2 2026. 641 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • JBGlobal.com held 1,550 shares of Novartis worth $221K as of Q3 2026.
  • JBGlobal.com left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.2% of JBGlobal.com's portfolio in Q3 2026, its #33 holding.
  • JBGlobal.com first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
  • JBGlobal.com's Novartis position peaked at $243K in Q2 2026.
  • 641 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on JBGlobal.com's 13F filing for Q3 2026, filed 13 Oct 2026.